From EFS to Pivotal Trials: Lessons Learned

Tuesday, February 28, 2023

8:08 AM – 8:16 AM ET

Speaker(s)

Aaron V. Kaplan, MD, FSCAI, FACC, FNAI

Professor of Medicine
Dartmouth Health Geisel School of Medicine at Dartmouth
Lebanon, New Hampshire, United States

Disclosure(s): Bard Peripheral Vascular, Veryan, Biotronik, Cook Medical, Gore & Associates, Medtronic, Philips, Terumo, TriReme, Shockwave, Med Alliance, Intact Vascular, B. Braun; CSI, Boston Scientific, University of Jena, Pluristem, PQ Bypass, Surmodics, Reflow: University Grants/Research Support (Ongoing); Boston Scientific: Clinical Trial Investigator (Ongoing), University Grants/Research Support (Ongoing); Conformal Medical, Inc.: Board Member (Ongoing), Officer or Board Member (Ongoing), Patent Holder (Ongoing), Stock-privately held company (Ongoing); Edwards Lifesciences LLC: University Grants/Research Support (Ongoing)

Disclosure(s):

Aaron V. Kaplan, MD, FSCAI, FACC, FNAI: Bard Peripheral Vascular, Veryan, Biotronik, Cook Medical, Gore & Associates, Medtronic, Philips, Terumo, TriReme, Shockwave, Med Alliance, Intact Vascular, B. Braun; CSI, Boston Scientific, University of Jena, Pluristem, PQ Bypass, Surmodics, Reflow: University Grants/Research Support (Ongoing); Boston Scientific: Clinical Trial Investigator (Ongoing), University Grants/Research Support (Ongoing); Conformal Medical, Inc.: Board Member (Ongoing), Officer or Board Member (Ongoing), Patent Holder (Ongoing), Stock-privately held company (Ongoing); Edwards Lifesciences LLC: University Grants/Research Support (Ongoing)